Biotest Aktiengesellschaft (BIO.DE)
EUR 41.4
(0.49%)
EUR 41.4
(0.49%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 689.8 Million EUR | 20.11% |
| 2022 | 574.3 Million EUR | 15.72% |
| 2021 | 496.3 Million EUR | 5.8% |
| 2020 | 469.1 Million EUR | 14.53% |
| 2019 | 409.6 Million EUR | 24.35% |
| 2018 | 329.4 Million EUR | -18.95% |
| 2017 | 406.4 Million EUR | 17.39% |
| 2016 | 346.2 Million EUR | 0.46% |
| 2015 | 344.6 Million EUR | 3.83% |
| 2014 | 331.9 Million EUR | 43.37% |
| 2013 | 231.5 Million EUR | 105.82% |
| 2012 | 112.47 Million EUR | 0.0% |
| 2011 | - EUR | 0.0% |
| 2010 | - EUR | 0.0% |
| 2009 | - EUR | 0.0% |
| 2008 | - EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| 2005 | - EUR | 0.0% |
| 2004 | - EUR | 0.0% |
| 2003 | - EUR | 0.0% |
| 2002 | - EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 693.2 Million EUR | 0.49% |
| 2024 Q2 | 624.3 Million EUR | -9.94% |
| 2023 Q2 | 662.1 Million EUR | 1.72% |
| 2023 FY | 689.8 Million EUR | 20.11% |
| 2023 Q4 | 689.8 Million EUR | -0.86% |
| 2023 Q3 | 695.8 Million EUR | 5.09% |
| 2023 Q1 | 650.9 Million EUR | 13.34% |
| 2022 Q1 | 534 Million EUR | 7.6% |
| 2022 FY | 574.3 Million EUR | 15.72% |
| 2022 Q4 | 574.3 Million EUR | 5.13% |
| 2022 Q3 | 546.3 Million EUR | 1.2% |
| 2022 Q2 | 539.8 Million EUR | 1.09% |
| 2021 Q3 | 505.1 Million EUR | 1.3% |
| 2021 Q2 | 498.6 Million EUR | 5.59% |
| 2021 Q1 | 472.2 Million EUR | 0.66% |
| 2021 Q4 | 496.3 Million EUR | -1.74% |
| 2021 FY | 496.3 Million EUR | 5.8% |
| 2020 Q3 | 468.4 Million EUR | 0.24% |
| 2020 FY | 469.1 Million EUR | 14.53% |
| 2020 Q1 | 411.8 Million EUR | 0.54% |
| 2020 Q4 | 469.1 Million EUR | 0.15% |
| 2020 Q2 | 467.3 Million EUR | 13.48% |
| 2019 Q4 | 409.6 Million EUR | -0.27% |
| 2019 Q2 | 354.8 Million EUR | 0.6% |
| 2019 Q3 | 410.7 Million EUR | 15.76% |
| 2019 FY | 409.6 Million EUR | 24.35% |
| 2019 Q1 | 352.7 Million EUR | 7.07% |
| 2018 FY | 329.4 Million EUR | -18.95% |
| 2018 Q4 | 329.4 Million EUR | -6.71% |
| 2018 Q3 | 353.1 Million EUR | -42.63% |
| 2018 Q2 | 615.5 Million EUR | 30.6% |
| 2018 Q1 | 471.3 Million EUR | 15.97% |
| 2017 FY | 406.4 Million EUR | 17.39% |
| 2017 Q4 | 406.4 Million EUR | -1.45% |
| 2017 Q3 | 412.4 Million EUR | -0.46% |
| 2017 Q2 | 414.3 Million EUR | 18.2% |
| 2017 Q1 | 350.5 Million EUR | 1.24% |
| 2016 Q1 | 349.2 Million EUR | 1.33% |
| 2016 FY | 346.2 Million EUR | 0.46% |
| 2016 Q4 | 346.2 Million EUR | -0.46% |
| 2016 Q3 | 347.8 Million EUR | -0.51% |
| 2016 Q2 | 349.6 Million EUR | 0.11% |
| 2015 Q4 | 344.6 Million EUR | -0.75% |
| 2015 FY | 344.6 Million EUR | 3.83% |
| 2015 Q1 | 344.4 Million EUR | 3.77% |
| 2015 Q2 | 348.4 Million EUR | 1.16% |
| 2015 Q3 | 347.2 Million EUR | -0.34% |
| 2014 Q2 | 246.7 Million EUR | 0.24% |
| 2014 FY | 331.9 Million EUR | 43.37% |
| 2014 Q4 | 331.9 Million EUR | 33.24% |
| 2014 Q3 | 249.1 Million EUR | 0.97% |
| 2014 Q1 | 246.1 Million EUR | 6.31% |
| 2013 Q2 | 102.6 Million EUR | 216.67% |
| 2013 Q3 | 98.1 Million EUR | -4.39% |
| 2013 Q4 | 231.5 Million EUR | 135.98% |
| 2013 FY | 231.5 Million EUR | 105.82% |
| 2013 Q1 | 32.4 Million EUR | -71.19% |
| 2012 Q3 | - EUR | 0.0% |
| 2012 Q4 | 112.47 Million EUR | 0.0% |
| 2012 FY | 112.47 Million EUR | 0.0% |
| 2012 Q1 | - EUR | 0.0% |
| 2012 Q2 | - EUR | 0.0% |
| 2011 Q2 | - EUR | 0.0% |
| 2011 FY | - EUR | 0.0% |
| 2011 Q3 | - EUR | 0.0% |
| 2011 Q4 | - EUR | 0.0% |
| 2011 Q1 | - EUR | 0.0% |
| 2010 Q4 | - EUR | 0.0% |
| 2010 FY | - EUR | 0.0% |
| 2010 Q3 | - EUR | 0.0% |
| 2010 Q2 | - EUR | 0.0% |
| 2010 Q1 | - EUR | 0.0% |
| 2009 FY | - EUR | 0.0% |
| 2009 Q4 | - EUR | 0.0% |
| 2008 FY | - EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| 2005 FY | - EUR | 0.0% |
| 2004 FY | - EUR | 0.0% |
| 2003 FY | - EUR | 0.0% |
| 2002 FY | - EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| BioNTech SE | 219.1 Million EUR | -214.833% |
| CureVac N.V. | 41.85 Million EUR | -1547.934% |
| Biotest Aktiengesellschaft | 689.8 Million EUR | 0.0% |
| BRAIN Biotech AG | 4.65 Million EUR | -14705.752% |
| Formycon AG | 29.48 Million EUR | -2239.415% |
| Heidelberg Pharma AG | 5.83 Million EUR | -11729.108% |
| Medigene AG | 2.95 Million EUR | -23283.051% |